BULLETIN V2026-2853
NUREXONE BIOLOGIC INC. ("NRX")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: September 9, 2026
TSX Venture Tier 2 Company
Financing Type: Non-Brokered Private Placement
Gross Proceeds: $1,066,078.02
Offering: 1,938,326 Listed Shares with 1,938,326 warrants attached
Offering Price: $0.55 per Listed Share
Warrant Exercise Terms: $0.69 per Listed Share for a 3-year period, subject to an acceleration right
Commissions in Securities:
N/A
Disclosure: Refer to the company's news release dated August 20, 2026
_______________________________________
|
|
